X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11513) 11513
Publication (798) 798
Newsletter (640) 640
Newspaper Article (135) 135
Magazine Article (84) 84
Book Review (39) 39
Book Chapter (11) 11
Conference Proceeding (8) 8
Dissertation (7) 7
Government Document (7) 7
Trade Publication Article (6) 6
Web Resource (2) 2
Book / eBook (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8526) 8526
male (5664) 5664
female (5074) 5074
albuterol - administration & dosage (4084) 4084
albuterol - therapeutic use (3899) 3899
asthma - drug therapy (3758) 3758
albuterol (3667) 3667
adult (3506) 3506
middle aged (2848) 2848
asthma (2802) 2802
albuterol - pharmacology (2665) 2665
administration, inhalation (2460) 2460
respiratory system (2328) 2328
index medicus (2024) 2024
bronchodilator agents - administration & dosage (2021) 2021
albuterol - analogs & derivatives (1990) 1990
bronchodilator agents - therapeutic use (1797) 1797
aged (1750) 1750
salmeterol xinafoate (1724) 1724
double-blind method (1711) 1711
adolescent (1708) 1708
salbutamol (1693) 1693
animals (1673) 1673
child (1597) 1597
asthma - physiopathology (1426) 1426
pharmacology & pharmacy (1376) 1376
nebulizers and vaporizers (1284) 1284
albuterol - adverse effects (1119) 1119
treatment outcome (1068) 1068
drug therapy, combination (1033) 1033
aerosols (1018) 1018
salmeterol (984) 984
adrenergic beta-agonists - therapeutic use (965) 965
dose-response relationship, drug (964) 964
adrenergic beta-agonists - pharmacology (881) 881
adrenergic beta-agonists - administration & dosage (834) 834
child, preschool (834) 834
time factors (830) 830
forced expiratory volume (813) 813
allergy (799) 799
children (779) 779
pediatrics (769) 769
drug therapy (764) 764
forced expiratory volume - drug effects (741) 741
fluticasone (709) 709
research (686) 686
pulmonary disease, chronic obstructive - drug therapy (675) 675
respiratory function tests (666) 666
medicine, general & internal (652) 652
acute disease (628) 628
cross-over studies (627) 627
bronchodilator agents - pharmacology (625) 625
drug combinations (580) 580
immunology (560) 560
infant (558) 558
rats (545) 545
formoterol fumarate (537) 537
analysis (532) 532
antiasthmatic agents (509) 509
heart rate - drug effects (502) 502
bronchodilator agents - adverse effects (495) 495
dosage and administration (492) 492
albuterol - chemistry (488) 488
androstadienes - administration & dosage (487) 487
clinical trials as topic (477) 477
in vitro techniques (472) 472
isoproterenol - pharmacology (469) 469
spirometry (458) 458
care and treatment (453) 453
prospective studies (439) 439
androstadienes - therapeutic use (434) 434
therapy (427) 427
health aspects (406) 406
severity of illness index (404) 404
drug administration schedule (403) 403
critical care medicine (400) 400
respiratory tract diseases (400) 400
particle size (398) 398
administration, oral (392) 392
asthma - diagnosis (392) 392
anti-asthmatic agents - therapeutic use (391) 391
albuterol - pharmacokinetics (386) 386
lung diseases, obstructive - drug therapy (386) 386
formoterol (385) 385
cardiac & cardiovascular systems (382) 382
copd (382) 382
anti-asthmatic agents - administration & dosage (373) 373
inhalation (373) 373
peak expiratory flow rate (372) 372
adrenergic beta-agonists - adverse effects (368) 368
corticosteroids (360) 360
guinea pigs (360) 360
obstructive pulmonary-disease (358) 358
drugs (357) 357
bronchi - drug effects (355) 355
ethanolamines - therapeutic use (354) 354
efficacy (350) 350
bronchial provocation tests (349) 349
lung diseases, obstructive (340) 340
research article (340) 340
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11400) 11400
French (211) 211
German (166) 166
Italian (136) 136
Spanish (115) 115
Polish (83) 83
Chinese (57) 57
Russian (55) 55
Japanese (54) 54
Portuguese (28) 28
Danish (19) 19
Dutch (15) 15
Romanian (12) 12
Croatian (9) 9
Norwegian (8) 8
Turkish (8) 8
Swedish (4) 4
Czech (3) 3
Hebrew (3) 3
Hungarian (3) 3
Korean (3) 3
Serbian (3) 3
Finnish (2) 2
Persian (1) 1
Slovak (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 04/2009, Volume 607, Issue 1-3, p. 151
The effects of salbutamol on contractility and cAMP levels were investigated in rat right ventricular myocardium. Salbutamol (1-300 [mu]M), produced a... 
Albuterol
Journal Article
Talanta, ISSN 0039-9140, 03/2008, Volume 75, Issue 1, p. 63
A new method for the determination of salbutamol has been developed using fullerene C.sub.60-modified glassy carbon electrode and validated using GC-MS. The... 
Albuterol
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 10/2004, Volume 170, Issue 8, pp. 836 - 844
Journal Article
Annals of Emergency Medicine, ISSN 0196-0644, 2016, Volume 68, Issue 4, pp. S50 - S50
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.annemergmed.2016.08.138 Byline: S. Morgan, P. Matthews, M.A. Papas,... 
Emergency | Albuterol
Journal Article
Molecular Genetics and Metabolism, ISSN 1096-7192, 01/2017, Volume 120, Issue 1-2, pp. S142 - S142
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3
Journal Article
Annals of Emergency Medicine, ISSN 0196-0644, 2015, Volume 66, Issue 4, pp. S136 - S136
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2011, Volume 128, Issue 2, pp. 315 - 322
Journal Article
Pediatrics, ISSN 0031-4005, 12/2017, Volume 140, Issue 6, p. S218
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 06/2011, Volume 337, Issue 3, pp. 600 - 609
beta(2)-Adrenoceptor (beta(2)-AR) agonists are powerful bronchodilators and play a pivotal role in the management of pulmonary obstructive diseases, such as... 
BETA-ADRENOCEPTOR AGONISTS | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | ASTHMA | PHARMACOLOGY & PHARMACY | BETA-2-ADRENOCEPTOR AGONIST | SELECTIVITY | BURDEN | BETA-ADRENERGIC RECEPTOR | SALMETEROL | COPD | Adrenergic beta-2 Receptor Agonists - pharmacokinetics | Ethanolamines - pharmacology | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Albuterol - pharmacology | Humans | Half-Life | Pulmonary Disease, Chronic Obstructive - physiopathology | Ethanolamines - administration & dosage | Adrenergic beta-2 Receptor Agonists - pharmacology | Bronchodilator Agents - chemistry | Ethanolamines - pharmacokinetics | Benzoxazines - pharmacokinetics | Albuterol - administration & dosage | Binding Sites | Benzoxazines - chemistry | Cricetinae | Salmeterol Xinafoate | Benzoxazines - administration & dosage | Adrenergic beta-2 Receptor Agonists - chemistry | Administration, Inhalation | Albuterol - analogs & derivatives | Albuterol - pharmacokinetics | Bronchodilator Agents - pharmacology | Receptors, Adrenergic, beta-1 - metabolism | Ethanolamines - chemistry | Asthma - drug therapy | Receptors, Adrenergic, beta-2 - metabolism | Animals | Bronchodilator Agents - pharmacokinetics | Benzoxazines - pharmacology | Adrenergic beta-2 Receptor Agonists - administration & dosage | Albuterol - chemistry | Mice | Mice, Inbred BALB C | Lipid Bilayers - metabolism | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Water Research, ISSN 0043-1354, 10/2017, Volume 123, p. 715
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.watres.2017.07.025 
Photolysis | Quinone | Albuterol | Sulfates
Journal Article
Journal of Chromatography B, ISSN 1570-0232, 05/2018, Volume 1084, p. 64
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.jchromb.2018.03.026 An... 
Analysis | Albuterol | Pork
Journal Article
Chest, ISSN 0012-3692, 12/2009, Volume 136, Issue 6, pp. 1456 - 1465
Background: Osteoporosis is common in patients with COPD, but its prevalence and progression are not well characterized. Concerns have been raised over the... 
SURVIVAL | FRACTURE | OBSTRUCTIVE PULMONARY-DISEASE | BONE-MINERAL DENSITY | FLUTICASONE PROPIONATE | RESPIRATORY SYSTEM | INHALED CORTICOSTEROIDS | RISK | BUDESONIDE | SEVERITY | SALMETEROL | Bronchodilator Agents - therapeutic use | Bone Diseases, Metabolic - epidemiology | Prevalence | Prospective Studies | Albuterol - pharmacology | United States | Humans | Middle Aged | Fractures, Bone - epidemiology | Male | Fluticasone | Bone Diseases, Metabolic - complications | Female | Bronchodilator Agents - adverse effects | Osteoporosis - epidemiology | Salmeterol Xinafoate | Osteoporosis - chemically induced | Double-Blind Method | Risk Factors | Albuterol - analogs & derivatives | Bronchodilator Agents - pharmacology | Treatment Outcome | Pulmonary Disease, Chronic Obstructive - complications | Bone Diseases, Metabolic - chemically induced | Disease Progression | Bone Density - drug effects | Androstadienes - pharmacology | Osteoporosis - complications | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Fluticasone-Salmeterol Drug Combination | Androstadienes - adverse effects | Albuterol - adverse effects | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Osteoporosis | Complications and side effects | Development and progression | Lung diseases, Obstructive | Corticosteroids | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 03/2011, Volume 139, Issue 3, pp. 505 - 512
Background: Pneumonia is an important complication of COPD and is reported more often in patients receiving inhaled corticosteroids (ICSs). Little is known... 
C-REACTIVE PROTEIN | MORTALITY | OBSTRUCTIVE PULMONARY-DISEASE | COMMUNITY-ACQUIRED PNEUMONIA | ANTIMICROBIAL THERAPY | RESPIRATORY SYSTEM | FLUTICASONE PROPIONATE/SALMETEROL 250/50 | INHALED CORTICOSTEROIDS | EXACERBATIONS | RISK | RESPIRATORY-TRACT INFECTIONS | CRITICAL CARE MEDICINE | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Fluticasone | Adrenal Cortex Hormones - therapeutic use | C-Reactive Protein - metabolism | Pneumonia - mortality | Pneumonia - chemically induced | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Double-Blind Method | Pneumonia - epidemiology | Risk Factors | Kaplan-Meier Estimate | Administration, Inhalation | Albuterol - analogs & derivatives | Pulmonary Disease, Chronic Obstructive - complications | Adrenal Cortex Hormones - adverse effects | Androstadienes - administration & dosage | Albuterol - therapeutic use | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Usage | Pneumonia | Corticosteroids | Bacterial pneumonia | Research
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 12, pp. 1093 - 1103
Journal Article